Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
British Journal of Cancer|May 8, 2014
Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignanciesA R Tan, A Dowlati, M N Stein, et al.
ESMO Open|August 30, 2021
Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United StatesP Jain, J Gutierrez Bugarin, A Guha, et al.
ESMO Open|March 5, 2023
Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancerC M Rudin, A Cervantes, A Dowlati, et al.
British Journal of Cancer|February 25, 2009
Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancerZ Tang, R Du, S Jiang, et al.
ESMO Open|April 5, 2025
Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudyA C Chiang, M E Olmedo Garcia, J W Carlisle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation studyD S Hong, T M Bauer, J J Lee, et al.
Pageof 4